1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Allena Pharmaceuticals Inc (ALNA)

  7. Allena Pharmaceuticals Inc (ALNA) Financials

ALNA

Allena Pharmaceuticals Inc
0.075
0.00 (0.0%)
Upgrade to Real-Time

Allena Pharmaceuticals Inc. (ALNA) Fundamentals
Allena Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. The company is focused on metabolic disorders that result in excess accumulation of certain metabolites, such as oxalate and urate, that can cause kidney stones, damage the kidney, and potentially lead to chronic kidney disease, or CKD, and end-stage renal disease. The company's product candidate, reloxaliase, is a first-in-class, oral enzyme therapeutic for the treatment of hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate levels and commonly associated with kidney stones, CKD and other serious kidney diseases.
SHARE INFORMATION
Market CapUS$ 9,156,242
Shares Outstanding122,083,226
Float120,965,326
Percent Float99.08%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -0.73
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions53
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months229,600
Institutional Holdings Percent12.0%
Institutional Sold Previous 3 Months3,406,110
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months-
Insider Holdings Percent3.4
Insider Sold Previous 3 Months-
Insider Shares Owned4,139,014
TRADING INFO
52 Week HighUS$ 1.17
52 Week LowUS$ 0.06
52 Week High ChangeUS$ -92.72
21 Day Moving AverageUS$ 0.1061
21 Day Extended Moving AverageUS$ 0.103578
50 Day Moving AverageUS$ 0.1357
50 Day Extended Moving AverageUS$ 0.12334
200 Day Moving AverageUS$ 0.30153
200 Day Extended Moving AverageUS$ 0.335651
10 Day Average Volume36,308,284
20 Day Average Volume21,729,545
30 Day Average Volume21,305,619
50 Day Average Volume36,913,632
Alpha-0.056317
Beta1.1326
Standard Deviation0.262633
R20.049661
7 Day Price ChangeUS$ -0.0275
7 Day Percent Change-26.83%
21 Day Price ChangeUS$ -0.0394
21 Day Percent Change-34.44%
30 Day Price ChangeUS$ -0.062
30 Day Percent Change-45.26%
Month to Date Price ChangeUS$ -0.0301
Month to Date Percent Change-28.64%
Quarter to Date Price ChangeUS$ -0.116
Quarter to Date Percent Change-60.73%
180 Day Price ChangeUS$ -0.428
180 Day Percent Change-85.09%
200 Day Price ChangeUS$ -0.3362
200 Day Percent Change-81.76%
Year to Date Price ChangeUS$ -0.5175
Year to Date Percent Change-87.34%

Allena Pharmaceuticals Inc. (ALNA) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.40
Total Debt To Equity1.40
Int Coverage-69.20
Current Ratio1.60
Leverage Ratio2.00
Quick Ratio0.60
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio-0.10
Enterprise ValueUS$ 7,570,450
Price to Sales0.00
Price to Free Cash-0.20
PE High Last 5 Years-1.60
Price To Book2.40
Price To Cash Flow0.00
PE Low Last 5 Years-5.40
Price to Tangible Book2.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-180.07
Return on Equity-541.02
Return on Capital-272.23

Allena Pharmaceuticals Inc. (ALNA) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEO-
Emplyoees21
Last AuditUE
CIK0001624658
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
AddressOne Newton Executive Park
Suite 202
Newton, MA 2462
Websitehttps://www.allenapharma.com
Facsimile+1 617 916-1871
Telephone+1 617 467-4577
Emailinfo@allenapharma.com
Your Recent History
NASDAQ
ALNA
Allena Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230325 06:52:49